Actuate Therapeutics, Inc.
ACTU
$7.22
$0.314.49%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 75.64% | 53.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.62% | -0.78% | |||
| Operating Income | -21.62% | 0.78% | |||
| Income Before Tax | -7.96% | 9.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.96% | 9.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.96% | 9.15% | |||
| EBIT | -21.62% | 0.78% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 40.52% | 86.79% | |||
| Normalized Basic EPS | 30.63% | 86.88% | |||
| EPS Diluted | 40.52% | 86.79% | |||
| Normalized Diluted EPS | 30.63% | 86.88% | |||
| Average Basic Shares Outstanding | 81.47% | 587.99% | |||
| Average Diluted Shares Outstanding | 81.47% | 587.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
